Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
11 November 2022 - 9:02AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO
RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of November 2022
Commission File Number: 001-39137
AnPac Bio-Medical Science Co., Ltd.
(Registrant’s name)
801 Bixing Street, Bihu County
Lishui, Zhejiang Province 323006
The People’s Republic of China
(Address of principal executive office)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F x
Form 40-F ¨
Indicate by
check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b) (1): ¨
Indicate by
check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b) (7): ¨
Explanatory Note:
Resignation of Directors
and Committee Members
On November
7, 2022, Yuyang Cui resigned from the position as (i) the Co-Chair of the board of the directors and (ii) the Co-Chief Executive Officer
of the Registrant, effective as of November 7, 2022.
On November
4, 2022, Jiawen Kang resigned from the position as (i) a director, (ii) a member of the audit committee, and (iii) a member of the nominating
and corporate governance committee of the Registrant, effective as of November 4, 2022.
EXHIBIT INDEX
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
AnPac Bio-Medical Science Co., Ltd. |
|
|
(Registrant) |
|
|
|
Date: November 10, 2022 |
By: |
/s/ Haohan Xu |
|
Name: |
Haohan Xu |
|
Title: |
Co-Chief Executive Officer |
AnPac Bio Medical Science (NASDAQ:ANPC)
Historical Stock Chart
From Mar 2024 to Apr 2024
AnPac Bio Medical Science (NASDAQ:ANPC)
Historical Stock Chart
From Apr 2023 to Apr 2024